Literature DB >> 19808229

The alphabet soup of kidney transplantation: SCD, DCD, ECD--fundamentals for the practicing nephrologist.

Panduranga S Rao1, Akinlolu Ojo.   

Abstract

There is significant variability in the quality of deceased-donor kidneys that are used for transplantation. The quality of the donor kidney has a direct effect on important clinical outcomes such as acute rejection, delayed graft function, and patient and allograft survival. Expanded-criteria donors (ECDs) refer to older kidney donors (> or =60 yr) or donors who are aged 50 to 59 yr and have two of the following three features: Hypertension, terminal serum creatinine >1.5 mg/dl, or death from cerebrovascular accident. By definition, ECD kidneys have a 70% greater likelihood of failure compared with one from a 35-yr-old male donor who died from a motor vehicle accident. Donation after cardiac death (DCD) is a small but rapidly growing fraction of donors. An ECD kidney transplant recipient has a projected average added-life-years of 5.1 yr compared with 10 yr for a kidney recipient from a standard-criteria donor. Kidney transplantation from DCD seems to have similar allograft and patient survival compared with kidney from donation after brain death; however DCD transplantation has a 42 to 51% risk for delayed graft function (need for at least one dialysis treatment during the first week after transplantation) compared with 24% in an standard-criteria donor kidney transplant. Familiarity with the comprehensive allocation rules governing different categories of deceased-donor kidneys by the nephrologists and dialysis team providers is essential to maximizing patient autonomy and to improve the outcomes of kidney transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19808229     DOI: 10.2215/CJN.02270409

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  47 in total

Review 1.  New Solutions to Reduce Discard of Kidneys Donated for Transplantation.

Authors:  Peter P Reese; Meera N Harhay; Peter L Abt; Matthew H Levine; Scott D Halpern
Journal:  J Am Soc Nephrol       Date:  2015-09-14       Impact factor: 10.121

2.  Anti-CD47 monoclonal antibody therapy reduces ischemia-reperfusion injury of renal allografts in a porcine model of donation after cardiac death.

Authors:  Min Xu; Xuanchuan Wang; Babak Banan; Danielle L Chirumbole; Sandra Garcia-Aroz; Aparna Balakrishnan; Deepak K Nayak; Zhengyan Zhang; Jianluo Jia; Gundumi A Upadhya; Joseph P Gaut; Ronald Hiebsch; Pamela T Manning; Ningying Wu; Yiing Lin; William C Chapman
Journal:  Am J Transplant       Date:  2017-12-02       Impact factor: 8.086

3.  Survival and hospitalization for intensive home hemodialysis compared with kidney transplantation.

Authors:  Karthik K Tennankore; S Joseph Kim; Heather J Baer; Christopher T Chan
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

4.  Predicting potential survival benefit of renal transplantation in patients with chronic kidney disease.

Authors:  Carl van Walraven; Peter C Austin; Greg Knoll
Journal:  CMAJ       Date:  2010-03-29       Impact factor: 8.262

Review 5.  Kidney donation after circulatory death (DCD): state of the art.

Authors:  Dominic M Summers; Christopher J E Watson; Gavin J Pettigrew; Rachel J Johnson; David Collett; James M Neuberger; J Andrew Bradley
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

6.  Intravenous infusion of ulinastatin attenuates acute kidney injury after cold ischemia/reperfusion.

Authors:  Yunpeng Wang; Cheng Peng; Zheng Zhang; Jing Shi; Yingli Lin; Liangyou Gu; Xin Ma; Hongzhao Li
Journal:  Int Urol Nephrol       Date:  2019-07-22       Impact factor: 2.370

Review 7.  Direct oral anticoagulant considerations in solid organ transplantation: A review.

Authors:  David M Salerno; Demetra Tsapepas; Apostolos Papachristos; Jae-Hyung Chang; Spencer Martin; Mark A Hardy; Jaclyn McKeen
Journal:  Clin Transplant       Date:  2016-12-28       Impact factor: 2.863

8.  Glutathione S-transferase iso-enzymes in perfusate from pumped kidneys are associated with delayed graft function.

Authors:  I E Hall; R S Bhangoo; P P Reese; M D Doshi; F L Weng; K Hong; H Lin; G Han; R D Hasz; M J Goldstein; B Schröppel; C R Parikh
Journal:  Am J Transplant       Date:  2014-02-24       Impact factor: 8.086

9.  Impact of Deceased Donor Management on Donor Heart Use and Recipient Graft Survival.

Authors:  Elizabeth A Swanson; Tony Adams; Madhukar S Patel; Salvador De La Cruz; Michael Hutchens; Kiran Khush; Mitchell B Sally; Claus U Niemann; Tahnee Groat; Darren J Malinoski
Journal:  J Am Coll Surg       Date:  2020-06-17       Impact factor: 6.113

10.  Continuous Normothermic Ex Vivo Kidney Perfusion Improves Graft Function in Donation After Circulatory Death Pig Kidney Transplantation.

Authors:  J Moritz Kaths; Juan Echeverri; Yi Min Chun; Jun Yu Cen; Nicolas Goldaracena; Ivan Linares; Luke S Dingwell; Paul M Yip; Rohan John; Darius Bagli; Istvan Mucsi; Anand Ghanekar; David R Grant; Lisa A Robinson; Markus Selzner
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.